Agnes B Fogo Selected Research

Agnes B Fogo Research Topics

Disease

37	Fibrosis (Cirrhosis) 03/2024 - 05/2002
28	Proteinuria 01/2024 - 07/2002
18	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023 - 06/2002
17	Chronic Renal Insufficiency 01/2023 - 07/2006
16	Glomerulonephritis 01/2024 - 07/2003
15	Inflammation (Inflammations) 02/2024 - 12/2005
15	Sclerosis 05/2022 - 06/2002
14	Kidney Diseases (Kidney Disease) 04/2024 - 06/2010
12	Albuminuria 12/2023 - 01/2007
8	Hypertension (High Blood Pressure) 12/2023 - 06/2002
8	Atherosclerosis 01/2019 - 06/2002
8	Body Weight (Weight, Body) 01/2016 - 01/2004
7	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 03/2024 - 10/2005
6	Ureteral Obstruction 12/2019 - 10/2003
6	Lupus Nephritis 05/2016 - 11/2002
6	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2014 - 02/2003
5	Infections 01/2024 - 04/2004
5	Membranous Glomerulonephritis (Membranous Nephropathy) 04/2022 - 10/2004
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 11/2012
4	Renal Insufficiency (Renal Failure) 01/2023 - 02/2003
4	Hematuria 01/2023 - 11/2018
4	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2022 - 12/2005
4	Hereditary Nephritis (Alport Syndrome) 08/2021 - 12/2005
4	Necrosis 01/2021 - 11/2002
4	Amyloidosis 12/2014 - 07/2003
4	Obesity 05/2011 - 02/2004
4	Insulin Resistance 03/2011 - 02/2004
3	Hyperglycemia 12/2023 - 02/2004
3	Ischemia 01/2022 - 07/2003
3	Hypoxia (Hypoxemia) 01/2021 - 01/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2006
3	Vasculitis (Vasculitides) 01/2021 - 02/2002
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 12/2014 - 08/2003
3	Dyslipidemias (Dyslipidemia) 10/2014 - 12/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2012 - 04/2004
3	Diabetes Mellitus 05/2008 - 03/2004
3	Thrombosis (Thrombus) 12/2005 - 06/2002
2	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 01/2020
2	Anemia 01/2023 - 01/2023
2	Atrophy 01/2023 - 11/2021
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022 - 01/2012
2	COVID-19 08/2020 - 01/2020
2	Rare Diseases (Rare Disease) 01/2019 - 10/2017
2	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 01/2018 - 11/2015
2	Hyperoxaluria (Oxaluria) 11/2017 - 08/2002

Drug/Important Bio-Agent (IBA)

17	CollagenIBA 03/2024 - 01/2004
14	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2003
14	Plasminogen Activator Inhibitor 1IBA 12/2019 - 05/2002
13	Plasminogen Activators (Plasminogen Activator)IBA 12/2019 - 05/2002
12	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 10/2004
10	CreatinineIBA 01/2024 - 07/2002
8	Messenger RNA (mRNA)IBA 10/2021 - 02/2004
8	Type 1 Angiotensin ReceptorIBA 12/2011 - 12/2002
7	Immunoglobulin A (IgA)IBA 01/2024 - 12/2012
7	Angiotensin IIIBA 06/2014 - 02/2006
7	PPAR gammaIBA 01/2012 - 06/2002
6	AldosteroneIBA 05/2022 - 05/2002
6	AngiotensinsIBA 05/2011 - 10/2003
5	LipidsIBA 02/2024 - 12/2005
5	CytokinesIBA 02/2024 - 12/2007
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
5	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2022 - 02/2002
5	AutoantibodiesIBA 04/2022 - 12/2005
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 04/2009
4	AntibodiesIBA 10/2023 - 07/2010
4	isolevuglandinIBA 11/2022 - 01/2021
4	Losartan (Cozaar)FDA LinkGeneric 05/2022 - 11/2005
4	antiglomerular basement membrane antibodyIBA 04/2022 - 09/2004
4	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2022 - 05/2002
4	Apolipoproteins E (ApoE)IBA 01/2019 - 09/2009
4	SaltsIBA 06/2014 - 02/2005
4	Insulin (Novolin)FDA Link 05/2011 - 06/2002
4	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 10/2003
4	Hydralazine (Apresoline)FDA LinkGeneric 04/2010 - 11/2005
3	EpitopesIBA 04/2022 - 07/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 03/2016
3	Enalapril FDA LinkGeneric 01/2022 - 11/2017
3	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
3	Protein Isoforms (Isoforms)IBA 11/2019 - 01/2004
3	Immunoglobulin G (IgG)IBA 01/2019 - 04/2012
3	Immunotoxins (Immunotoxin)IBA 01/2019 - 04/2005
3	CholesterolIBA 01/2018 - 09/2009
3	Angiotensin Receptor AntagonistsIBA 11/2014 - 04/2009
3	Fibrinolysin FDA Link 06/2014 - 05/2002
2	AntioxidantsIBA 12/2023 - 06/2020
2	Uremic ToxinsIBA 01/2023 - 08/2011
2	Antihypertensive Agents (Antihypertensives)IBA 05/2022 - 11/2005
2	Discoidin Domain Receptor 1IBA 01/2022 - 01/2019
2	Congo RedIBA 01/2022 - 01/2019
2	ParaffinIBA 01/2022 - 07/2014
2	ApolipoproteinsIBA 10/2021 - 08/2011
2	Collagen Type IV (Type IV Collagen)IBA 08/2021 - 11/2018
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 11/2019
2	TenascinIBA 12/2019 - 09/2015
2	AutoantigensIBA 01/2019 - 07/2010
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017 - 10/2012

Therapy/Procedure

18	Therapeutics 04/2024 - 10/2004
6	Nephrectomy 01/2021 - 07/2003
4	Transplantation 11/2021 - 12/2005
3	Kidney Transplantation 01/2020 - 03/2003